Christopher Creighton

Christopher Creighton is an accomplished professional in the pharmaceutical field, currently serving as Senior Director of Process Chemistry and API Manufacture at Sterling Pharma Solutions since August 2023. As an Independent Consultant for Isotide since January 2022, Christopher leverages extensive industry experience that includes roles as General Partner at Intelibis Research from July 2018 to December 2021, Director of Research and Development and later Associate Director of Chemistry at Hamari, USA from 2011 to July 2018, and Principal Scientist at Trius Therapeutics from 2006 to 2010. Prior experience includes a Senior Scientist role at Johnson & Johnson Pharmaceutical Research & Development from 2000 to 2006, and a foundational education with a Ph.D. in Organic Chemistry and a B.S. in Chemistry from the University of California at San Diego, completed between 1995 and 2000 and 1990 and 1995, respectively.